Alerts will be sent to your verified email
Verify Email
ANUHPHR
|
Anuh Pharma
|
Zim Laboratories
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.0 | 7.69 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
15.87 % | 6.9 % | 7.31 % |
|
5yr average Equity Multiplier
|
1.62 | 1.84 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
1.35 | 0.89 | 0.56 |
|
5yr Avg Net Profit Margin
|
7.23 % | 3.99 % | 8.44 % |
|
Price to Book
|
2.23 | 2.24 | 2.3 |
|
P/E
|
19.14 | 113.6 | 21.31 |
|
5yr Avg Cash Conversion Cycle
|
42.81 Days | 35.94 Days | 14.76 Days |
|
Inventory Days
|
50.87 Days | 73.14 Days | 14.42 Days |
|
Days Receivable
|
111.12 Days | 105.27 Days | 136.16 Days |
|
Days Payable
|
117.6 Days | 144.59 Days | 212.73 Days |
|
5yr Average Interest Coverage Ratio
|
48.66 | 3.9 | 6.02 |
|
5yr Avg ROCE
|
21.17 % | 11.83 % | 11.26 % |
|
5yr Avg Operating Profit Margin
|
10.21 % | 11.23 % | 12.28 % |
|
5 yr average Debt to Equity
|
0.02 | 0.38 | 0.17 |
|
5yr CAGR Net Profit
|
10.73 % | -16.69 % | 48.72 % |
|
5yr Average Return on Assets
|
9.84 % | 3.78 % | 4.99 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.8 % | 30.35 % | 63.77 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.21 % | -2.91 % | -4.48 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Anuh Pharma
|
Zim Laboratories
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|